Lobbying Arrangements: Pharmacy
New Lobbying Registrations About Pharmacy By Quarter
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Promotion of federal legislation related to reimbursement for provision of care for those living with HIV/AIDS. |
Mylan Inc.
|
Evertz Group LLC | |||
Details Assisting client with regulatory hurdles in some developing world countries receiving assistance from the USG |
Gilead Sciences
|
Evertz Group LLC | |||
Details H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Health Care Act: issues related to the regulation of biologics. |
ABRAXIS BIOSCIENCE, INC.
|
K&L GATES LLP | |||
Details Followon Biologics Super MedPAC HRSA - 340B Drug Pricing Program/Pharmacy Affairs |
Pfizer, Inc.
|
AMERICAN CONTINENTAL GROUP | |||
Details The 340B Drug Pricing Program; The Protect 340B Act; FY24 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations bill. HR 3290,to amend title III of th... |
340B Health
|
in-house lobbying | |||
Details Funding for Veteran programs through advanced appropriations |
Downey McGrath Group Inc (on behalf of the Disabled American Veterans)
|
Mr. Ed Greelegs | |||
Details Issues pertaining to health care reform and physician payment transparency. Issues pertaining to pharmaceutical supply chain and drug safety. |
The Pew Charitable Trusts
|
The Glover Park Group LLC | |||
Details Issues related to Section 340B of the Public Health Service Act; FDA issues; health reform implementation. |
Allergan, Inc.
pharmaceutical, biological and medical device manufacturer |
MCDERMOTT WILL & EMERY LLP | |||
Details Pharmaceutical Manufacturing; Pharmacy Issues; Clinical Pharm-Assist; Medicare Prescription Drug Benefits; American's Health Choices Act (HR 3200), Regulations under MMA re: Medicare Prescription ... |
Strativa Pharmaceuticals
|
DUMBARTON GROUP & ASSOCIATES, LLC | |||
Details issue is on-line pharmacies |
Eli Lilly
|
B & D CONSULTING | |||
Details Adoption of secure pharmaceutical prescription technology |
Standard Register Corporation
|
PARK STRATEGIES, LLC | |||
Details Drug Utilization Review Program, Competitive bidding, HR 5597: Medicare Patient IVIG Access Demonstration Project, Medical Loss Ratio, Performance-Based Pharmacy Reimbursement, PDUFA & Biosimilars,... |
Medco Health Solutions, Inc and its Subsidiaries
|
STRATEGIES 360 | |||
Details Legalization of medical cannabis. |
Americans for Safe Access
|
Mr. David Krahl | |||
Details Representation regarding appropriations, mental health, medicare and medicaid |
UHS of Delaware, Inc.
|
Parker, Poe, Adams & Bernstein LLP | |||
Details Issues related to municipal appropriations, transportation, water and economic development. Issues related to federal appropriations for healthcare research. Issues related to federal appropriation... |
Hance Scarborough LLP
|
ARNOLD & PORTER LLP | |||
Details Mail Order Perscription Drugs, Independant Pharmacies |
Managed Pharmacy Care
Employed by Managed Pharmacy Care |
MS. SHEILA HIXSON | |||
Details Communications, Video, and Technology Accessibility Act; Websites and Software Applications Accessibility Act; Exercise and Fitness for All Act; Medical Device Nonvisual Accessibility Act; Medicare... |
American Council of the Blind
|
American Council of the Blind Inc | |||
Details Medicare D |
PhRMA (on behalf of We Work for Health )
|
Capitol Strategies Group, LLC | |||
Details Federal legislation affecting the practice of pharmacy and FDA regulation of compounded drugs. |
Texas Academy of Compounding Pharmacists
|
HANCE SCARBOROUGH | |||
Details Quality improvement and cost containment of health care through prevention and better management of chronic disease; H.R 3590; H.R. 3962 |
PhRMA (on behalf of We Work for Health and Partnership to Fight Chronic Disease)
|
APCO WORLDWIDE INC. | |||
Details Repeal of medical device tax. Repeal of medical device tax |
BioOhio
|
Colby & Company | |||
Details The 340B Drug Pricing Program; The Protect 340B Act; FY24 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations bill. HR 3290,to amend title III of th... |
340B Health
|
in-house lobbying | |||
Details The 340B Drug Pricing Program; The Protect 340B Act; FY24 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations bill. HR 3290,to amend title III of th... |
340B Health
|
in-house lobbying | |||
Details H.R. 3843, the Merger Filing Fee Modernization Act of 2021, provisions related to reform of antitrust laws. H.R. 3460, the State Antitrust Enforcement Venue Act of 2021, provisions related to refo... |
Strategic Organizing Center
|
in-house lobbying | |||
Details Implementation of the Patient Protection and Affordable Care Act; Issues related to government efforts to roll out the COVID vaccination system. Discussions surrounding pending tax related provisio... |
PhRMA (on behalf of We Work for Health)
|
Capitol Legislative Strategies LLC | |||
Details Biodefense; Biomedical Advanced Research and Development Authority funding; vaccine research, development, manufacturing and marketing; infectious diseases; PAHPA; Labor-HHS-ED appropriations bills... |
Bavarian Nordic Inc.
|
in-house lobbying | |||
Details None |
Energizer Personal Care
|
VAN FLEET ASSOCIATES, INC. | |||
Details Healthcare issues. |
Scottsdale Healthcare
|
Edwards Wildman Palmer LLP | |||
Details no specific bills Sickle Cell Anemia education and research advocacy |
GlycoMimetics, Inc.
|
TARPLIN, DOWNS & YOUNG, LLC | |||
Details Healthcare Reform ARRA of 2009 DMEPOS Accreditation Omnibus Budget of 2010 |
eRx Network, LLC
|
in-house lobbying |